USPTO Extends "Patents 4 Patients" Pilot Program
Last summer, we wrote about the “Patents 4 Patients” Cancer Immunotherapy Pilot Program launched by the USPTO. At the program’s…
Read more
USPTO to Replace EFS and PAIR
As part of its efforts to modernize and improve the patent filing system, the USPTO presented an overview of the…
USPTO Launches "Patents 4 Patients": A Cancer Immunotherapy Program
OVERVIEW The Cancer Immunotherapy Pilot Program (also known as “Patents 4 Patients”) provides accelerated review without requiring a petition fee…